Delek US holdings director sells $281k in stock

Director Yemin Ezra Uzi of Delek US Holdings (NYSE:DK) sold a total of 7,388 shares of common stock on October 29, 2025. The sales were executed at a weighted average price of $38.08, with prices ranging from $38.00 to $38.30 per share, resulting in a total transaction value of $281,335. The transaction comes as DK trades near its 52-week high of $39.28, having surged 191.4% over the past six months and 163.1% over the last year. According to InvestingPro analysis, the stock appears overvalued at current levels.

Of the shares sold, 1,581 were directly owned, while 5,807 were indirectly held by Yemin Investments, LP. Following the transactions, Yemin directly owns 166,580.047 shares and indirectly owns 723,145 shares.

The sales were conducted pursuant to a Rule 10b5-1 plan. Investors should note that Delek US Holdings is scheduled to release earnings in 6 days on November 7, 2025. InvestingPro identifies several challenges for the company, including a significant debt burden and weak cash flow, with analysts not anticipating profitability this year. The company does offer a 2.67% dividend yield and has raised its dividend for 3 consecutive years. Discover 15+ additional ProTips and comprehensive analysis in DK’s Pro Research Report.

In other recent news, Delek US Energy reported its Q2 2025 earnings with an adjusted EPS of -$0.56, which was better than the forecasted -$0.86. The company also exceeded revenue expectations, reporting $2.76 billion compared to the anticipated $2.67 billion. Additionally, Delek US announced a quarterly dividend of $0.255 per share, payable on November 17, 2025, to shareholders of record as of November 10, 2025.

Morgan Stanley upgraded Delek US’s stock rating from Underweight to Equalweight, influenced by the EPA’s decision to grant exemptions to numerous small refineries. Similarly, TD Cowen upgraded the stock from Sell to Hold, citing the financial benefits of small refinery exemptions, which are expected to boost the company’s EBITDA by at least $150 million annually. Wolfe Research also upgraded Delek US to Outperform, highlighting the company’s significant year-to-date stock performance and its advantage over industry peers. These developments reflect a positive shift in analyst sentiment towards Delek US.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.